Welcome

AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.

Events

03/31/2022 | LEADERSHIP4SME START-UP PITCH SESSION
LEADERSHIP4SMEs is a project funded by the European Union in the scope of the... More

01/17/2022 | V edition of CHEMOSTART
AROMICS one of the participant companies in the Chemostart 5th Edition program... More

News

01/20/2022 | AROMICS - one of the winners of Chemostart V Edition Program
ChemoStart is a global programme which provides support for startups and companies designing... More

12/16/2021 | Aromics wishes you Merry Christmas and Happy New Year 2021
... More